Three thousand South Africans will take part in the first large-scale trial of an HIV vaccine that has already been tested on smaller groups in the U.S., Canada, Latin America, the Caribbean and Australia. With 5.5 million people believed to be living with the virus, South Africa has one of the world’s highest HIV rates.